Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 227 results found. Search for [ gilead ]

Results 1 to 21 of 227
PTI
May 5, 2021
If the US gives up intellectual property rights, it will harm innovation and production, and result in fewer people getting vaccinated, the 12 influential Congressmen said in a letter to US Trade Representative Katherine Tai


PB Jayakumar
May 3, 2021
Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing


BusinessToday.In
April 30, 2021
Gilead will dispatch 75,000 to 1,00,00 vials in the next one or two days. Further, 100,000 will also be supplied before or by May 15. EVA Pharma will supply 10,000 vials initially, followed by 50,000 every 15 days or till July


PTI
April 28, 2021
The US maintains a moral obligation to assist our ally India as they face severe challenges posed by COVID-19, Congressman Brad Sherman said


BusinessToday.In
April 27, 2021
The equity value is an all-cash offer of Rs 3,015 crore for a 96.42% stake in JPL including 3,400 MW coal-fired power plants in the state of Chhattisgarh and other non-core assets owned by JPL.


PTI
April 27, 2021
In addition to providing support to its licensees to expand their local manufacturing capacity, Gilead will also donate at least 450,000 vials of Remdesivir to help address the immediate needs of Indian patients


BusinessToday.In
April 23, 2021
Although it has been approved as an investigational drug for strict use under hospital conditions, Remdesivir has seen a surge in demand over the last few days as the country battles the second wave of COVID-19 cases, leading to its shortage


BusinessToday.In
April 20, 2021
Based on information, the police arrested two individuals, Yogiraj Rajkumar Waghmare and Parag Vijaykumar Patil, and seized 11 bottles of injection from them.


BusinessToday.In
April 19, 2021
Jubilant Pharma says oral formulation is an affordable, more convenient, easy-to-administer and potentially effective treatment option for COVID-19 patients


Rai Vinaykumar
April 14, 2021
Fast-track approval has been given for seven additional sites having production capacity of 10 lakh vials/month. Another 30 lakh vials/month production is lined up.


BusinessToday.In
April 12, 2021
Stocks in focus in today's trade: TCS, Infosys, Balrampur Chini Mills, Pharma stocks, Barbeque Nation Hospitality and more


BusinessToday.In
April 11, 2021
Seven Indian companies producing Remdesivir injections under voluntary licensing agreement with US-based Gilead Sciences have an installed capacity of about 38.80 lakh units per month


BusinessToday.In
March 24, 2021
This move to further revise the prices will go a long way in helping patients during these critical times, the company said.


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


BusinessToday.In
December 16, 2020
Rapid antigen detection test directly detects presence or absence of coronavirus antigen in patient's body, generating results in 15-20 minutes; ICMR-approved CIPtest is found to have specificity and sensitivity of 98.09 per cent and up to 75 per cent


Reuters
November 20, 2020
WHO suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients


Reuters
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise


PB Jayakumar
November 18, 2020
Cipla will sell these kits across 25 markets in Asia, Middle-East and North Africa, Latin America, EU and Australia


Reuters
November 9, 2020
Remdesivir was developed by US drugmaker Gilead Sciences, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of treatment


BusinessToday.In
October 26, 2020
Gold, Silver prices today: Gold, viewed as a hedge against inflation and currency debasement has risen over 25% this year, supported by unprecedented monetary stimulus from major central banks


PAGES 1 OF 12  12345